Atlas Trials

Phase I Study of MOv18 IgE

Clinical trial NCT02546921 · COMPLETED

Trial details

NCT number
NCT02546921
Sponsor
Cancer Research UK
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Human Cancers
Start date
2016-02-16
Primary completion
2021-06-22
Enrollment
26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.